Oral Abrocitinib for Treatment of Refractory Alopecia Areata: A Retrospective Study

October 2024 in “ Journal of the American Academy of Dermatology ”

Yujing Zhang, Xiaodong Fang, Xiangqian Li, Yan Zhao, Jianzhong Zhang, Wei Zhao, Cheng Zhou

abrocitinib JAK1 inhibitor alopecia areata Severity of Alopecia Score SALT folliculitis

Studysummary Abrocitinib may help treat alopecia areata effectively with mild side effects.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata

4 citations , January 2024 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

This consensus statement outlines a treatment algorithm for alopecia areata, detailing systemic treatment indications and options, including EMA-approved medications baricitinib and ritlecitinib for severe cases, as well as other off-label treatments and adjuvant therapies like oral minoxidil.

research Successful Treatment of Alopecia Universalis With Abrocitinib: A Case Report

19 citations , August 2023 in “Journal of Dermatological Treatment”

This case study reports that abrocitinib therapy led to clinical remission of alopecia universalis in a patient with a history of drug-induced DRESS, suggesting its potential as a treatment option.